EMA — authorised 1 February 2013
- Application: EMEA/H/C/002532
- Marketing authorisation holder: Sanofi Winthrop Industrie
- Local brand name: Zaltrap
- Indication: Treatment of metastatic colorectal cancer (MCRC).
- Status: approved
🇪🇺 Ziv aflibercept in European Union
EMA authorised Ziv aflibercept on 1 February 2013
Marketing authorisation
Other Ophthalmology approved in European Union
Frequently asked questions
Is Ziv aflibercept approved in European Union?
Yes. EMA authorised it on 1 February 2013.
Who is the marketing authorisation holder for Ziv aflibercept in European Union?
Sanofi Winthrop Industrie holds the EU marketing authorisation.